Answer
Breastfeeding should be discontinued during treatment with Ontozry (cenobamate) as a precaution because excretion into human milk is unknown and a risk to the breastfed child cannot be excluded.
Sources for this answer
- Ontozry 200 mg film-coated tabletsAngelini Pharma UK-I Limited (Formerly Arvelle Therapeutics UK) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked